➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Mallinckrodt
Dow
AstraZeneca
Harvard Business School

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Brincidofovir

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Brincidofovir?

Brincidofovir is an investigational drug.

There have been 12 clinical trials for Brincidofovir. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.

The most common disease conditions in clinical trials are Adenoviridae Infections, Cytomegalovirus Infections, and Virus Diseases. The leading clinical trial sponsors are Chimerix, SymBio Pharmaceuticals, and Food and Drug Administration (FDA).

There are seven US patents protecting this investigational drug and eighty international patents.

Recent Clinical Trials for Brincidofovir
TitleSponsorPhase
Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy SubjectsSymBio PharmaceuticalsPhase 1
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus ViremiaChimerixPhase 2
The AdAPT Trial; Adenovirus After Allogeneic Pediatric TransplantationChimerixPhase 2

See all Brincidofovir clinical trials

Clinical Trial Summary for Brincidofovir

Top disease conditions for Brincidofovir
Top clinical trial sponsors for Brincidofovir

See all Brincidofovir clinical trials

US Patents for Brincidofovir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Brincidofovir   Start Trial Phosphonate ester derivatives and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Compounds, compositions and methods for treating ocular conditions Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Phosphonate ester derivatives and methods of synthesis thereof Chimerix Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Phosphonate compounds The Regents of the University of California (Oakland, CA)   Start Trial
Brincidofovir   Start Trial Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Brincidofovir

Drugname Country Document Number Estimated Expiration Related US Patent
Brincidofovir Australia AU2011295937 2030-08-31   Start Trial
Brincidofovir Brazil BR112013004925 2030-08-31   Start Trial
Brincidofovir Canada CA2809679 2030-08-31   Start Trial
Brincidofovir China CN103209985 2030-08-31   Start Trial
Brincidofovir China CN105218580 2030-08-31   Start Trial
Brincidofovir China CN105998039 2030-08-31   Start Trial
Brincidofovir European Patent Office EP2611818 2030-08-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Mallinckrodt
Dow
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.